S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature

Vivos Therapeutics (VVOS) News Today

$5.49
-0.32 (-5.51%)
(As of 03/1/2024 ET)
SourceHeadline
benzinga.com logoVivos Therapeutics Stock (NASDAQ:VVOS), Short Interest Report
benzinga.com - February 22 at 12:09 PM
benzinga.com logoVivos Therapeutics Stock (NASDAQ:VVOS) Insider Trades
benzinga.com - February 22 at 7:09 AM
investing.com logoVivos Therapeutics secures $4 million through warrant exercise
investing.com - February 18 at 12:39 AM
finance.yahoo.com logoVivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
finance.yahoo.com - February 15 at 9:27 AM
proactiveinvestors.com logoVivos Therapeutics sees gross proceeds of $4M from exercise of warrant
proactiveinvestors.com - February 15 at 9:13 AM
finance.yahoo.com logoVivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
finance.yahoo.com - February 12 at 9:45 AM
finanznachrichten.de logoVivos Therapeutics, Inc: Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
finanznachrichten.de - February 6 at 10:18 AM
finance.yahoo.com logoVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
finance.yahoo.com - February 6 at 10:18 AM
finance.yahoo.com logoVivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
finance.yahoo.com - January 8 at 9:45 AM
marketbeat.com logo
marketbeat.com - December 18 at 2:37 PM
proactiveinvestors.com logoVivos Therapeutics announces women-led airway health event
proactiveinvestors.com - December 11 at 12:22 PM
finance.yahoo.com logoVivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
finance.yahoo.com - December 11 at 12:22 PM
marketbeat.com logoBlack Swan: this small cap surged over 1000% last week
marketbeat.com - December 4 at 6:03 AM
proactiveinvestors.com logoVivos Therapeutics severe sleep apnea treatment’s a ‘breakthrough’, says CEO
proactiveinvestors.com - December 1 at 8:28 PM
benzinga.com logoThinking about buying stock in Minim Inc, Walmart, Farfetch Ltd, Qualcomm, or Vivos Therapeutics Inc?
benzinga.com - November 30 at 1:04 PM
investorplace.com logoWhy Is Vivos Therapeutics (VVOS) Stock Down 35% Today?
investorplace.com - November 30 at 10:05 AM
msn.com logoPhilips shares slump as FDA says sleep product may overheat
msn.com - November 30 at 12:47 AM
proactiveinvestors.com logoVivos Therapeutics: Who is the medical device company creating frenzy in the markets?
proactiveinvestors.com - November 29 at 7:47 PM
marketbeat.com logo
marketbeat.com - November 29 at 3:56 PM
marketbeat.com logo
marketbeat.com - November 29 at 3:32 PM
marketbeat.com logo
marketbeat.com - November 29 at 3:19 PM
marketbeat.com logo
marketbeat.com - November 29 at 3:15 PM
marketbeat.com logo
marketbeat.com - November 29 at 3:01 PM
marketbeat.com logo
marketbeat.com - November 29 at 2:51 PM
proactiveinvestors.com logoVivos Therapeutics receives first ever FDA 510(k) clearance...Vivos Therapeutics receives first ever FDA 510(k) clearance for...
proactiveinvestors.com - November 29 at 2:43 PM
msn.com logoVivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance
msn.com - November 29 at 2:43 PM
finance.yahoo.com logoUPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea
finance.yahoo.com - November 29 at 2:43 PM
finance.yahoo.com logoVivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea
finance.yahoo.com - November 29 at 2:43 PM
marketbeat.com logo
marketbeat.com - November 29 at 2:35 PM
investorplace.com logoWhy Is Vivos Therapeutics (VVOS) Stock Up 290% Today?
investorplace.com - November 29 at 1:01 PM
marketbeat.com logo
marketbeat.com - November 29 at 10:55 AM
marketbeat.com logo
marketbeat.com - November 29 at 10:51 AM
marketbeat.com logo
marketbeat.com - November 29 at 10:42 AM
marketbeat.com logo
marketbeat.com - November 29 at 9:59 AM
marketbeat.com logo
marketbeat.com - November 29 at 9:41 AM
reuters.com logoUS FDA clears Vivos Therapeutics' oral device treatment for sleep apnea
reuters.com - November 29 at 8:28 AM
markets.businessinsider.com logoVivos Receives FDA 510(k) Clearance For Removable Oral Appliances For Severe OSA
markets.businessinsider.com - November 29 at 8:28 AM
markets.businessinsider.com logoVivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
markets.businessinsider.com - November 29 at 8:28 AM
msn.com logoVivos stock rallies after FDA clears oral device treatment for severe sleep apnea
msn.com - November 29 at 8:28 AM
finance.yahoo.com logoVivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
finance.yahoo.com - November 29 at 8:28 AM
finanznachrichten.de logoVivos Therapeutics, Inc: Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
finanznachrichten.de - November 15 at 8:15 AM
finance.yahoo.com logoVivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update
finance.yahoo.com - November 14 at 8:49 PM
finance.yahoo.com logoVivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
finance.yahoo.com - November 9 at 7:28 PM
finance.yahoo.com logoVivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare
finance.yahoo.com - November 3 at 5:37 PM
proactiveinvestors.com logoVivos Therapeutics closes $4M private placement
proactiveinvestors.com - November 3 at 12:37 PM
finance.yahoo.com logoVivos Therapeutics Closes $4 Million Private Placement
finance.yahoo.com - November 2 at 8:56 PM
msn.com logoVivos Therapeutics (VVOS) Price Target Increased by 2400.00% to 45.90
msn.com - November 1 at 6:22 PM
msn.com logoVivos Therapeutics prices $4M public offering
msn.com - October 31 at 9:46 AM
finance.yahoo.com logoVivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - October 31 at 9:46 AM
proactiveinvestors.com logoVivos Therapeutics reveals 1-for-25 reverse stock split
proactiveinvestors.com - October 26 at 1:16 PM
Get Vivos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter.



VVOS Media Mentions By Week

VVOS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VVOS
News Sentiment

1.44

0.64

Average
Medical
News Sentiment

VVOS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VVOS Articles
This Week

2

2

VVOS Articles
Average Week

Get Vivos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VVOS) was last updated on 3/2/2024 by MarketBeat.com Staff